To determine the impact of increased donor heart RIPK1-dependent cell death on graft survival, we exposed B6 Sharpincpdm hearts to 8 hours of CIS and transplanted them into CTLA4Ig-treated BALB/c recipients (Figure 1D). The gene discussed is RIPK1; the disease is in situ carcinoma.